• Mechanism
  • Findings
  • Study quality

Peptide science, read closely.

Alpha Helix reads the primary peptide literature so the evidence is easy to follow. Every compound gets the same treatment: how it works, what it is studied for, what the studies found and at what doses, and how strong that evidence really is.

One base pair per finding, colored by its evidence tier

The compound library

Twenty-five compounds, one format.

Mechanism of action, what each compound is most studied for, notable findings with the doses the studies used, and a plain read on study quality. Animal or human, said up front.

Every summary cites its sources by author and year.

Browse the full library

How we read the research

Every effect belongs to a study.

Four rules sit behind every page on this site. They are what make it citable, and they are why nothing here reads like a sales pitch.

01

An evidence tier.

FDA approved, human RCT, early human, animal or in vitro, minimal evidence. Named and shown on a five-rung meter on every compound and every study, so the strength of the evidence is never buried.

02

A species statement.

Rats, mice, human cells or people, said in the first lines. A result in a dish and a result in a trial are different claims.

03

A dose, as studied.

Doses appear exactly as a study reported them, with the species, route and duration. Research context, never guidance.

04

A live citation.

Authors, year and a PubMed, trial registry or DOI link on every finding. If it cannot be cited, it is not published.

Latest research

The number is the headline.

Findings, trials and regulatory moves from the research desk, newest first. Each study opens with the most striking figure it produced or, when it produced none, the species it was done in.

Just in

    The Evidence Map

    Graded by the strongest evidence behind each.

    The full watchlist, grouped by evidence tier. Each tile opens that compound's research summary. Updated monthly.

    Regulatory Radar

    What is actually legal right now.

    FDA, PCAC, 503A and 503B status: what moved, on what date, and what it does not mean.

    Free guide

    Want more? Get the free guide.

    The compound pages are the short version. Leave your email and we’ll send you our free research guide.

    If you’d like to talk through your practice, a project, or anything else you have going on, add a note and we’ll get back to you.

    Send me the guide

    We use your details only to send the guide and reply to you. See the privacy policy.

    The Alpha Helix Brief

    One email a week. Sundays.

    What landed in the peptide literature this week, each item with its evidence tier, the species it was done in and a live citation, plus what moved on the Evidence Map. Unsubscribe in one click.

    Read the latest issue ↗